splinting are necessary to prevent recurrence.
Nailbed Reconstruction
Eponychial fold and decreasing range of motion of the distal interphalangeal joint (DIP). To improve
the DIP range of motion and proximal to the DIPJ releasing the skin proximally and distally taking care
not to injure the underlying extensor tendon. A full thickness graft is then placed (Fig. 12-12).
ASSOCIATED COMPLICATIONS OF BURN INJURIES
Muscle Catabolism and Wasting
Burn injury involving large areas of the body is associated with significant pathophysiologic sequelae,
which can persist up to several years after the acute injury. There are significant changes in essential
metabolic processes, which shift physiologic homeostasis to a catabolic state, resulting in loss of lean
body mass. The TBSA affected by the burn injury plays an important role, since reestablishing a
functional skin barrier initially takes priority and requires a protein substrate, which is often provided
by skeletal muscle.105
Muscle catabolism after burn injury is mediated by several factors including increased energy
requirement106 and heightened inflammatory state involving the systemic release of stress hormones,
catecholamines, and glucocorticoids, which mediate the underlying metabolic derangements. Other
factors include prolonged immobilization and the loss of a functional skin barrier, which lead to
disturbed thermoregulation requiring increased energy expenditure to maintain body temperature. The
consequences can have devastating effects on the convalescence of pediatric burn patients, where an
increased catabolic state can lead to delayed linear growth for up to 2 years after the injury.107 The
physiologic response of skeletal muscle to anabolic stimuli is altered in pediatric patients with amino
acid infusion therapy failing to stimulate a net protein deposition in skeletal muscle even 6 to 12
months post injury.108,109
Studies investigating the effect of burn injury on physiologic changes in skeletal muscle have
uncovered a critical role for mitochondrial function showing that processes involving carbohydrate
metabolism, lipid metabolism, and oxidative phosphorylation are significantly altered.110 Righi et al.111
demonstrated that treatment with a mitochondria-targeted antioxidant in a mouse burn model
significantly increases mitochondrial ATP secretion and ameliorates oxidative stress, suggesting that
reactive oxygen species play a significant role in burn pathogenesis. Improvements in skeletal muscle
mitochondrial function have also been attributed to the effect of fenofibrate, a peroxisome proliferatoractivated receptor-α agonist used to treat impaired glucose metabolism commonly observed after burn
injury. In pediatric burn patients, fenofibrate treatment improved glucose levels and insulin
sensitivity.112 Other therapeutic approaches, which have shown significant benefit in clinical trials
include the blockage of beta-adrenergic receptors, resulting in attenuated catecholamine effect and
improved net muscle protein balance.67 Anabolic steroids such as oxandrolone, and physical exercise
have been shown to increase lean body mass in children who suffered from >40% TBSA burn injury.113
When the body is in a prolonged catabolic state due to the increase in caloric requirements, patients
must consume at least 2.5 to 3 g/kg/day of protein.75 Nutritional shakes and high-calorie foods are a
necessity to optimize the conditions for wound healing. It is important to start nutrition as soon as
possible, preferentially using the enteric route. Nasogastric or nasoduodenal/jejunal feeding tubes
should be inserted early in the care of this patient population. Dieticians are crucial members of the
burn care team in creating individualized feeding plans and ensuring that nutrition is at the forefront of
daily care. Albumin and prealbumin levels can be trended over time to ensure that adequate
nourishment is achieved.
Patients should also be referred to physical and occupational therapy. A therapeutic exercise program
should be implemented to maintain normal range of motion, strength, and endurance. In order to
counteract the catabolic effects of burn injuries, a program of active and active-assisted exercise is
necessary. Depending on the severity of the burn and the patient’s willingness to tolerate the associated
pain with exercise, passive range of motion exercises should be prescribed. In the event that full range
of motion is not achievable, a program of stretching can be prescribed in its place. Anesthesia can be
used to assist these exercises when patients cannot tolerate pain.
Range of motion exercises can also minimize skin contractures, as skin is a tissue that requires
sustained mechanical stretch to facilitate lengthening of the underlying collagen and extracellular matrix
397
http://surgerybook.net/
compartments. Initial skin exercises should attempt to elongate the skin with repetitive low loads with
differences in length. Following this initial precondition, a prolonged stretch is applied to maximize skin
laxity. Blanching is a clinical sign that capillary blood flow is impeded and is a good sign that the tissue
has reached its maximum yield point. Strength exercise should follow as soon as the patient can tolerate
it. Strength programs best suited for burn patients should include progressive resistive exercises. Fatigue
and loss of endurance are major issues as a patient recovers. It is important to include endurance
training and monitor cardiopulmonary response. Concurrently, patients should be encouraged to walk as
ambulating patients have fewer lower extremity contractures, endurance problems, and venous
thrombosis.
Heterotopic Ossification
Heterotopic ossification (HO) is the pathologic formation of bone in extraskeletal regions of soft tissue
including muscle, joint spaces, and often encasing major nerves (Fig. 12-13). This complication of burn
injury causes significant pain, joint restriction, and contractures.113 The incidence of HO is proportional
to the severity of the injury with an increased incidence in severely burned patients. HO may affect all
areas of the body but is most frequently encountered in the elbow joint (Fig. 12-13).114,115 While the
etiology of HO remains elusive, common risk factors that have been identified include upper extremity
burns, large TBSA burns, young age, prolonged immobilization116 and a delay in time to wound
closure.117
Early detection and diagnosis of heterotopic bone formation is critical in the clinical management of
this complication, which oftentimes involves surgical resection. The success rates of surgical
intervention are not well established and are associated with a high recurrence rate. Perioperative
radiotherapy has been suggested as an adjunct to surgical resection and has been shown to reduce the
recurrence rate to some extent.118 While the pathophysiologic processes underlying the development of
heterotopic bone formation are poorly understood, several studies have implicated increased
inflammatory signaling and the involvement of progenitor cells as crucial contributing elements.
Pharmacologic interventions have been shown to have some efficacy in limiting the severity of HO.
Bisphosphonates and non-steroidal anti inflammatory have been used for prophylaxis and treatment of
HO with some success.119,120 However, there is no consensus on which drug should be prescribed and
when treatment should begin. It has been proposed that bisphosphonates should be prescribed as soon
as elevated alkaline phosphatase is noted or imaging studies establish the presence of HO. NSAIDs limit
the severity of HO when delivered as a preventative therapy. The primary pathway thought to play a
role is the bone morphogenetic protein (BMP) receptor 1 pathway; specifically the ALK2 kinase domain
which stimulates canonical smad signaling. Though diagnosis is often not made until after 3 to 4 weeks
after the burn injury, pathologic changes occur much sooner and thus treatments should target this early
osteogenic signaling if prophylaxis is to be achieved. The effect of early active and passive range of
motion on HO is unknown. Though the elbow is the most common site, the reason for this high
incidence is unknown.
398
http://surgerybook.net/
Figure 12-13. Heterotopic ossification.
Marjolin’s Ulcer
Similar to chronic wounds from other etiologies, chronic untreated burn scars can lead to malignant
degeneration. Squamous cell carcinoma is the most common type of malignancy observed. Malignancies
are rare in an era of early excision and grafting. Malignancy requires wide excision with at least a 2 cm
margin as well as sentinel lymph node biopsy. If the sentinel node is positive, a compete lymph node
excision should be performed.
Clinical Research
Clinical research determines the safety and efficacy of medications, devices, diagnostic tools, and
treatment regimens and has provided new insights to effectively care for burn patients. Within the last
decade, critical care, wound care treatment, and burn reconstruction research have advanced in both
diagnosis and identification of efficacious therapies to improve the overall recovery process for burn
victims.
Critical care research has focused on the delivery of adequate care during the initial phase following
the traumatic burn injury. Immediately following the trauma, burn patients experience severe shock due
to concomitant inflammation leading to severe edema. While rigorous fluid resuscitation has been
shown to increase overall survival for patients with high TBSA involvement, novel resuscitation
methods have recently been investigated. In a prospective randomized study, clinicians investigated the
use of colloids within the first 24 hours of resuscitation.121 Patients with a TBSA burn injury greater
than 15% were either provided with crystalloid resuscitation or a mixture of crystalloid and
hydroxyethyl starch. Patients given colloids required less fluid, experienced less edema, and had a lower
C-reactive protein indicative of less inflammation. Additional studies have investigated the use of
therapeutic plasma exchange for refractory burn resuscitation and discovered that patients had reduced
lactate levels, increased mean arterial pressure, and improved urine output after treatment.122 Our
recommendation and common practice use crystalloid rather than colloid as outcomes in burn patients
have not been conclusively shown to be improved. These studies highlight the complexity of burn shock
resuscitation and the need for ongoing research in the field.
Studies have investigated the role of regulating glucose levels in burn patients during the critical
phase. Stress hyperglycemia after severe burn injury has long been established as a physiologic response
to trauma. Recent studies have demonstrated the need for early glycemic control, as burn patients who
did not have optimal glucose levels experienced increased mortality. Intensive insulin therapy in
critically ill burn patients limited the number of infections and sepsis and improved overall organ
function.123 In general moderate glycemic control as demonstrated by the NICE-SUGAR trial appears
399
http://surgerybook.net/
efficacious.124 Delivery of insulin also decreased inflammatory responses, as noted by decrease levels of
systemic IL-6 and C-reactive protein, and also improved body density, body fat, and lean body mass.
Insulin therapy also reduced resting energy expenditure in the first week following the burn injury,
improved mitochondrial function, and hepatic glucose metabolism.125 Furthermore, the glucose
variability experienced by a burn patient during the critical period is also associated with increased
mortality rates, suggesting that consistent and tight glucose control may provide a significant survival
benefit.126 Taken together, these studies build an argument that in burn patients, glucose control with
insulin therapy may reduce inflammation, improve energy utilization, and improve overall prognosis.
Another important area of research is the development of new technology to aid in wound assessment
and treatment. Punch biopsy, laser Doppler imaging, and near-infrared spectroscopy have been
employed to diagnosis the burn depth and severity of the primary wound site. Additional studies
advocate for the use of confocal laser scanning microscopy (CLSM) due to its greater contrast and
sensitivity. This technology images wounds in vivo without any physical dissection using a laser source.
CLSM was able to determine wound depth by assessing the number of perfused dermal papillae and was
able to accurately classify burns based on the amount of perfusion.127 Recent development of
extracorporeal shock wave treatment (ESWT) has shown promise as it promotes angiogenesis, increases
perfusion, and accelerates wound healing. In a pilot study, patients treated with ESWT demonstrated
increase blood flow to the burn wound within 3 weeks.128 This therapy shows great promise, as it is a
noninvasive measure to improve wound healing.
Advances in burn reconstruction have also been noted in the last decade. While TEs have been a
mainstay of burn reconstruction, several studies have surveyed the use of endoscopic-assisted placement
of expanders and the use of osmotic TEs.129,130 Both endoscope-assisted placement of expanders and
osmotic TEs offer advantages over the traditional methods, as they are more cosmetically acceptable
and require fewer injections, respectively. As TE technology continues to improve with new expansion
techniques and devices, discovering the best technique and devices will be an important component of
burn reconstruction. Cultured epithelial autografts, as discussed in previous sections, have gained
interest as an alternative for cutaneous coverage for patients with large burn wounds and small
potential donor sites. With final engraftment percentages as high as 73% and 90% patient survival rate,
it is an attractive alterative for patients with severe and extensive burns.
BASIC SCIENCE AND TRANSLATIONAL SCIENCE RESEARCH
Basic science and translational science research in burn injuries have significantly advanced in the last
50 years and have focused on both understanding and treating the primary wound site as well as
complications that arise from these traumatic burn injuries.
Wound healing can be described in three different stages: inflammation, proliferation, and remodeling
phase. Hypertrophic scarring is an aberrant form of the normal wound healing process that does not
extend beyond the original wound margins. Hypertrophic scar formation involves the constitutively
active proliferative phase of wound healing, resulting in high vascularity and dense extracellular matrix
deposition.131 Histologic studies suggest that a robust inflammatory response, involving mast cells,
macrophages, fibrocytes, and lymphocytes, may underlie the excessive fibrosis seen in hypertrophic scar
formation.132 The secretion of TGF-beta1, platelet-derived growth factors (PDGFs), and epidermal
growth factor contributes to the inflammatory response and results in excessive inflammatory cell
stimulation, fibroblast proliferation, adhesion, neovascularization, matrix production, and ultimately
contraction.133 As such, translational science research from the bench to the bedside focuses on new
therapies targeted at quenching the inflammatory response, limiting fibrosis, and inhibiting
angiogenesis by targeting the mediators of this scaring process.134,135 Additional basic science research
aimed at understanding the wound healing process and translational science research investigating new
treatment options will continue to advance our understanding and treatment of burn-related injuries.
Additional studies into the precise cause of secondary complications such has HO has gained
significant interest due to the increase in presence of HO in veterans who have sustained combat
injuries. While the precise pathophysiology behind HO is still unclear, it is thought to be related to local
and systemic factors, causing osteoblastic differentiation of local cells. Previous studies have attempted
to elucidate the local and systemic wound inflammatory response leading to HO, through the
identification of cytokine and chemokines secreted from the wound.136 Serum analysis demonstrated a
profound systemic inflammatory response in burn patients, as burn patients maintained increased levels
of IL-6 and macrophage chemoattractant protein (MCP)-1 over time. Both IL-6 and MCP-1 are
400
http://surgerybook.net/
No comments:
Post a Comment
اكتب تعليق حول الموضوع